# Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy

> **NCT07537283** · NA · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 39 (actual)

## Conditions studied

- Epilepsy
- Drugs Resistance

## Interventions

- **DIETARY_SUPPLEMENT:** coenzyme Q10
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07537283
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-07
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-11-28
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537283, "Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07537283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*